OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

1.85
Delayed Data
As of May 22
 -0.04 / -2.12%
Today’s Change
1.74
Today|||52-Week Range
4.33
-19.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-14.7M-21.1M-31.8M-26.2M
 
 
 
 
 
Depreciation75.0K100.0K227.0K223.0K
 
 
 
 
 
Total Other Cash Flow-6.2M-4.1M-3.0M-2.9M
 
 
 
 
 
Funds From Operations-20.8M-25.1M-34.7M-28.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-535.0K18.4M1.3M-11.5M
 
 
 
 
 
Net Cash Flow - Operating Activities-20.3M-43.5M-35.9M-17.4M
 
 
 
 
 
 
InvestingIncrease In Investments-75.1M-110.4M-31.7M-19.4M
 
 
 
 
 
Decrease In Investments100.3M89.5M64.4M24.9M
 
 
 
 
 
Capital Expenditures-79.0K-291.0K-253.0K-82.0K
 
 
 
 
 
Net Cash Flow Investing25.1M-21.2M32.4M5.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale219.0K54.2M10.0K25.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.0029.0K
 
 
Net Cash Flow - Financing219.0K54.2M10.0K25.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-40.0K0.009.0K-1.0K
 
 
 
 
 
Net Change In Cash5.0M-10.4M-3.5M13.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account